Voloridge Investment Management
IOVA icon

Voloridge Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

Voloridge Investment Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Sell
688,134
-334,646
-33% -$1.27M 0.01% 617
2026
Q1 		$3.59M Buy
+1,022,780
New +$3.27M 0.01% 739
2024
Q4 		– Sell
-109,953
Closed -$1.03M – 1271
2024
Q3 		$1.03M Sell
109,953
-2,381,706
-96% -$22.6M ﹤0.01% 1018
2024
Q2 		$20M Sell
2,491,659
-1,002,525
-29% -$10.7M 0.07% 369
2024
Q1 		$51.8M Buy
3,494,184
+2,511,104
+255% +$29.2M 0.19% 152
2023
Q4 		$7.99M Buy
983,080
+782,656
+391% +$4.1M 0.03% 522
2023
Q3 		$912K Sell
200,424
-329,718
-62% -$2.15M ﹤0.01% 1116
2023
Q2 		$3.73M Sell
530,142
-598,771
-53% -$4.29M 0.02% 777
2023
Q1 		$6.9M Sell
1,128,913
-581,929
-34% -$4.01M 0.03% 568
2022
Q4 		$10.9M Buy
1,710,842
+267,794
+19% +$2.09M 0.06% 405
2022
Q3 		$13.8M Buy
1,443,048
+437,941
+44% +$5.05M 0.07% 356
2022
Q2 		$11.1M Buy
1,005,107
+259,895
+35% +$3.41M 0.06% 406
2022
Q1 		$12.4M Buy
745,212
+141,536
+23% +$2.19M 0.07% 351
2021
Q4 		$11.5M Sell
603,676
-34,758
-5% -$765K 0.06% 425
2021
Q3 		$15.7M Sell
638,434
-55,183
-8% -$1.3M 0.1% 273
2021
Q2 		$18M Buy
693,617
+609,506
+725% +$15.8M 0.13% 213
2021
Q1 		$2.66M Buy
84,111
+47,800
+132% +$1.98M 0.02% 716
2020
Q4 		$1.69M Buy
+36,311
New +$1.44M 0.01% 797

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Voloridge Investment Management's IOVA Position: Q2 2026 in Review

Voloridge Investment Management reduced its Iovance Biotherapeutics (IOVA) stake by 33% in Q2 2026, selling an estimated $1.27M and leaving 688,134 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #617.

Voloridge Investment Management first reported a position in IOVA in Q4 2020 and has held it in 18 quarters since. The position peaked at $51.8M in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Voloridge Investment Management held 688,134 shares of Iovance Biotherapeutics worth $2.86M as of Q2 2026.
  • Voloridge Investment Management sold 334,646 Iovance Biotherapeutics shares in Q2 2026, an estimated $1.27M.
  • Iovance Biotherapeutics made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #617 holding.
  • Voloridge Investment Management first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 18 quarters since.
  • Voloridge Investment Management's Iovance Biotherapeutics position peaked at $51.8M in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.